Haoxi Health Technology Ltd
4 hedge funds and large institutions have $248K invested in Haoxi Health Technology Ltd in 2024 Q2 according to their latest regulatory filings, with 4 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
48,042% more capital invested
Capital invested by funds: $515 → $248K (+$247K)
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$78.7K |
| 2 |
Invesco
Atlanta,
Georgia
|
+$78.7K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$59K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$59K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$18 |
HAO Hedge Fund Activity: Q2 2024 in Review
4 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Haoxi Health Technology Ltd (HAO) for Q2 2024, worth a combined $248K — up 48,042% from $515 a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new HAO positions and 0 closed out — a net gain of 4 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $78.7K. The largest seller was JP Morgan Chase, cutting an estimated $18.
- 4 institutional investors held Haoxi Health Technology Ltd (HAO) as of Q2 2024, up from 0 in Q1 2024.
- Funds reported $248K of Haoxi Health Technology Ltd stock for Q2 2024, up 48,042% quarter-over-quarter.
- 4 funds opened new Haoxi Health Technology Ltd positions in Q2 2024 and 0 closed out, a net change of +4 holders.
- The largest Haoxi Health Technology Ltd buyer in Q2 2024 was HRT Financial, an estimated $78.7K added.
- The largest Haoxi Health Technology Ltd seller in Q2 2024 was JP Morgan Chase, an estimated $18 sold.
Based on aggregated 13F filings for Q2 2024.